Medical Clowning: Needs Assessment and Implication for Hospitalized Children With Cancer/Blood Disease
August 6, 2020 updated by: National Taiwan University Hospital
Medical Clowning: Needs Assessment, Implication, and Evaluation for Children and Adolescents With Cancer Using Child Friendly Healthcare
Hospitalized children who undergo painful procedures are more susceptible than others to experiencing iatrogenic effects, such as anxiety, pain, and severe stress.
Clowns in clinical setting have been found to be effective in reducing children's experiences of these effects during hospitalization and before procedures.
This article provides an overview of clowning in health care settings; reviews major studies conducted on clowning for hospitalized children, discussing evidence that clown interventions decrease pain and distress in pediatric patients; and concludes with a discussion of health care clowning as a profession.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
148
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Taipei, Taiwan, 100
- National Taiwan Universtiy Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
aged 4-18 children with cancer/blood disease and parents of children aged 0-18 years with cancer/blood disease
Description
Inclusion Criteria:
- aged 4-18 children with cancer/blood disease and parents of children aged 0-18 years with cancer/blood disease
Exclusion Criteria:
- older than aged 18
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
children and their parents
aged 4-18 children with cancer/blood disease and their parents
|
Clowns in clinical setting have been found to be effective in reducing children's experiences of these effects during hospitalization and before procedures.
|
|
Dr. Clowns
they will perform shows for children and parents
|
Clowns in clinical setting have been found to be effective in reducing children's experiences of these effects during hospitalization and before procedures.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
experience and influence from medical clowning for children and their parents
Time Frame: 1 year
|
Children with cancer/blood disease and their parents would use self-report to complete the questionnaire after medical clowning.
Using Face Rating Scale (1=very unhappy to 5=very happy) for measuring emotion state (pre-emotion for before medical clowning and post-emotion for after medical clowning).
It can understand whether their emotion state change before/after medical clowning or not.
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 7, 2018
Primary Completion (Actual)
March 31, 2020
Study Completion (Actual)
March 31, 2020
Study Registration Dates
First Submitted
June 4, 2018
First Submitted That Met QC Criteria
July 12, 2018
First Posted (Actual)
July 13, 2018
Study Record Updates
Last Update Posted (Actual)
August 10, 2020
Last Update Submitted That Met QC Criteria
August 6, 2020
Last Verified
May 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 201803121RINB
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.